Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
24.46
+0.58 (2.43%)
Jun 29, 2026, 3:11 PM EDT - Market open
Sanara MedTech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -33.58 | -37.57 | -9.91 | -4.44 | -8.09 | -7.99 |
Depreciation & Amortization | 3.41 | 3.95 | 4.92 | 3.68 | 2.37 | 0.6 |
Stock-Based Compensation | 4.88 | 5.15 | 4.44 | 3.44 | 2.7 | 2.67 |
Other Adjustments | 5.46 | 34.28 | 1.44 | -2.64 | -3.05 | 1.1 |
Change in Receivables | -2.15 | -0.07 | -4.54 | -1.73 | -2.27 | -0.77 |
Changes in Inventories | -0.41 | -1.78 | 1.44 | -1.55 | -0.52 | -1.15 |
Changes in Accounts Payable | -1.22 | 0.81 | -0.47 | 0.58 | -0.42 | 0.1 |
Changes in Accrued Expenses | 1.69 | 2.42 | 3.68 | -0.82 | 4.15 | 1.13 |
Changes in Other Operating Activities | -0.08 | -0.4 | -1.02 | 0.24 | -0.42 | -0.48 |
Operating Cash Flow | 6.32 | 6.79 | -0.02 | -3.25 | -5.55 | -4.81 |
Capital Expenditures | -2.95 | -4.63 | -0.21 | -0.27 | -0.15 | -0.17 |
Sale of Property, Plant & Equipment | - | 0.06 | - | 0 | 0 | - |
Purchases of Intangible Assets | -0.01 | -0.02 | -0.02 | - | -0.6 | -0.58 |
Purchases of Investments | -4.75 | -8.26 | -6.38 | - | -0.25 | -4.53 |
Payments for Business Acquisitions | -1.06 | -2.12 | - | -9.94 | -2.52 | - |
Investing Cash Flow | -9.84 | -14.97 | -6.61 | -10.21 | -3.51 | -5.28 |
Short-Term Debt Issued | - | - | - | - | - | 0.8 |
Short-Term Debt Repaid | - | - | -9.75 | - | - | -0.8 |
Net Short-Term Debt Issued (Repaid) | - | - | -9.75 | - | - | 0 |
Long-Term Debt Issued | -0.04 | 12.02 | 29.34 | 9.69 | - | - |
Long-Term Debt Repaid | -0.83 | -1.65 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | -0.87 | 10.37 | 29.34 | 9.69 | - | - |
Issuance of Common Stock | - | - | -0.08 | 0.91 | - | 28.94 |
Repurchase of Common Stock | -0.94 | -0.55 | -0.13 | -0.14 | - | -0.44 |
Net Common Stock Issued (Repurchased) | -0.94 | -0.55 | -0.2 | 0.78 | - | 28.5 |
Other Financing Activities | -0.94 | -0.94 | -2.02 | -0.82 | -0.63 | -0.2 |
Financing Cash Flow | -3.58 | 8.89 | 17.37 | 9.64 | -0.63 | 28.3 |
Net Cash Flow | -7.09 | 0.7 | 10.73 | -3.81 | -9.69 | 18.2 |
Free Cash Flow | 3.37 | 2.16 | -0.23 | -3.51 | -5.7 | -4.99 |
Free Cash Flow Growth | 56.10% | - | - | - | - | - |
FCF Margin | 3.14% | 2.10% | -0.26% | -5.40% | -12.44% | -20.65% |
Free Cash Flow Per Share | 0.39 | 0.25 | -0.03 | -0.42 | -0.72 | -0.68 |
Levered Free Cash Flow | -32.38 | -26.82 | 18.27 | 7.25 | -2.93 | -7.9 |
Unlevered Free Cash Flow | 8.12 | 7.67 | 9.61 | -2.35 | -2.26 | -7.36 |